Showing 8891-8900 of 20877 results for "".
Reducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
https://reachmd.com/programs/frontlines-iga-nephropathy/reducing-proteinuria-and-function-loss-in-igan-a-recap-of-the-nefigard-trial/26940/Dive into a study focused on how the treatment option Nefecon may be able to reduce proteinuria and protect kidney function in IgAN patients.Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
https://reachmd.com/programs/neurofrontiers/examining-schizophrenia-risk-the-influence-of-b12-levels-in-early-pregnancy/32310/A recent study investigated how maternal B12 levels in early pregnancy might impact schizophrenia risk in offspring. Here’s what it found.Impacts on Access to Eye Care: Key Socioeconomic Factors
https://reachmd.com/programs/clinicians-roundtable/impacts-on-access-to-eye-care-key-socioeconomic-factors/14631/Have recent findings helped clinicians better identify socioeconomic factors among patients with glaucoma? Find out.Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
https://reachmd.com/diseases-diagnoses/alzheimer-disease-dementias/next-generation-cns-drug-delivery-brainshuttle-technology-and-clinical-implications-in-alzheimer-disease/67099/In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinical Development in Neuroscience and Rare Diseases at Roche, Basel, Switzerland, discusses the investigational Brainshuttle technology, including results from the BrainShuttle AD clinical trials as a treatment for early AlzNavigating Diagnostic Challenges in Food Protein-Induced Enterocolitis Syndrome
https://reachmd.com/programs/frontlines-food-allergies/navigating-diagnostic-challenges-in-food-protein-induced-enterocolitis-syndrome/30041/Food protein-induced enterocolitis syndrome (FPIES) is a rare, non-IgE-mediated food allergy in infants and young children that causes delayed, severe gastrointestinal symptoms without typical allergic signs. Learn about the challenges associated with diagnosing FPIES with Dr. Anna Nowak-Wegryzn, PrTwo Lenses on Migraine: Managing Incomplete Acute Treatment Response
https://reachmd.com/programs/innovations-in-medicine/two-lenses-on-migraine-managing-incomplete-acute-treatment-response/39226/Even with multiple acute treatment options available for migraine, many patients continue to experience suboptimal outcomes.1 However, terms like incomplete, insufficient, or inadequate response aren’t defined the same way across guidelines, consensus statements, research, or day-to-day clinical praThe Importance of Skin Barrier Repair in Atopic Dermatitis
https://reachmd.com/programs/practical-dermatology-updates-in-atopic-dermatitis/the-importance-of-skin-barrier-repair-in-atopic-dermatitis/57284/Naeim T. Issa, MD, PhD, FAAD, explains why patients with atopic dermatitis are notoriously barrier deficient and how aryl hydrocarbon receptor agonists can help address that issue.Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/early-detection-attr-cm-clinical-clues-imaging/49041/Identifying key cardiac and extracardiac red flags is essential in diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) early. Dr. Shelina Ramnarine is joined by Dr. Valmiki Maharaj to review the diagnostic pathway and explore how we can recognize ATTR-CM earlier in the disease course.Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
https://reachmd.com/programs/heart-matters/athlete-cpet-beyond-standardized-testing/54807/Cardiopulmonary exercise testing (CPET) provides critical insights into athletic performance when tailored to the individual and their sport-specific demands. Dr. Benjamin Levine shares insights on how to interpret key metrics and why customized testing approaches are so important in this populatioSurgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
https://reachmd.com/programs/project-oncology/surgery-gastroesophageal-cancer-surveillance-intervention/49171/For patients with locally advanced gastroesophageal cancer, surgery remains a critical component of curative treatment—even in the era of chemoradiation and advanced imaging. Dr. Daniela Molena explores the challenges of assessing complete clinical response and the risks of non-operative managem